Molecule intelOpportunity: ModerateEssentialCrowded market

Ephedrine

133 brands · 92 companies · product forms

ATC: C01CA26, R01AA03, R01AB05, R03CA02, S01FB02

Opportunity snapshot

Launch attractiveness
36
Market saturation
97
Price room
100
Regulatory risk
0
133
brands
92
companies
Rs 271.6
median price
24
price points
40.32x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 4%

Price room

Across observed sources and strengths
CheapestRs 16.71
MedianRs 271.6
Most expensiveRs 673.69
Spread40.32×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 40.32x across 24 trusted points (Rs 16.71-673.69). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Ephedrine — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(3) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

92 canonical companies and 133 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 40.32x across 24 trusted points (Rs 16.71-673.69). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.